How much funding has Laronde raised?

Laronde has raised $490.0M in total funding, most recently a Series B round.

Where is Laronde headquartered?

Laronde is headquartered in Cambridge, Massachusetts, United States.

What industry is Laronde in?

Laronde operates in Biotech, Healthcare.

Laronde

Q: Who are Laronde's investors?

Laronde's investors include Flagship Pioneering, Fidelity Management, T. Rowe Price, Mirae Asset.

Cambridge, United States · Founded 2017 · $490.0M raised

Biotech

Healthcare

Headquarters: Cambridge, Massachusetts
Employees: 11–50
Founded: 2017
Business Model: B2B

Website: laronde.bio
Total Funding: $490.0M
Last Round: $440.0M Series BAug 2021
Rounds: 2

About

Laronde is a biotechnology company pioneering Endless RNA (eRNA), a completely novel class of engineered RNA that can be programmed to express diverse proteins inside the body. Unlike conventional mRNA, eRNA is persistent, non-immunogenic, and supports repeat dosing with flexibility in formulation and delivery, enabling durable protein expression for a broad range of diseases. Founded in 2017 by Flagship Labs, the innovation foundry of Flagship Pioneering, Laronde is developing multiple therapeutic programs in parallel across many disease areas from its Cambridge, Massachusetts headquarters.

Summary

Laronde is a Biotech company based in Cambridge, United States, founded in 2017. It has raised $490.0M in total across 2 rounds, most recently a $440.0M Series B round in Aug 2021. Investors include Flagship Pioneering, Fidelity Management and T. Rowe Price.